Predicting differential antigen-antibody contact regions based on solvent accessibility

被引:11
作者
Lebeda, FJ
Olson, MA
机构
[1] Department of Cell Biology and Biochemistry, Toxinology Division, U.S. Army Medical Research Institute of Infectious Diseases, Frederick
来源
JOURNAL OF PROTEIN CHEMISTRY | 1997年 / 16卷 / 06期
关键词
botulinum neurotoxin; neural network algorithm; neutralizing determinant; type-specific antibody; vaccine;
D O I
10.1023/A:1026370807586
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A novel computational approach was examined for predicting epitopes from primary structures of the seven immunologically distinct botulinum neurotoxins (BoNT/A-G) and tetanus toxin (TeTX). An artificial neural network [Rost and Sander (1994), Proteins 20, 216] was used to estimate residue solvent accessibilities in multiple aligned sequences. A similar network trained to predict secondary structures was also used to examine this protein family, whose tertiary fold is presently unknown. The algorithm was validated by showing that it was 80% accurate in determining the secondary structure of avian egg-white lysozyme and that it correctly identified highly solvent-exposed residues that correspond to the major contact regions of lysozyme-antibody cocrystals. When sequences of the heavy (H) chains of TeTX and BoNT/A-G were analyzed, this algorithm predicted that the most highly exposed regions were clustered at the sequentially nonconserved N- and C-termini [Lebeda and Olson (1994), Proteins 20, 293]. The secondary structures and the remaining highly solvent-accessible regions were, in contrast, predicted to be conserved. In experiments reported by others, H-chain fragments that induced immunological protection against BoNT/A overlap with these predicted most highly exposed regions. It is also known that the C-terminal halves of the TeTX and BoNT/A H-chains interfere with holotoxin binding to ectoacceptors on nerve endings. Thus, the present results provide a theoretical framework for predicting the sites that could assist in the development of genetically engineered vaccines and that could interact with neurally located toxin ectoacceptors, Finally, because the most highly solvent-exposed regions were not well conserved. it is hypothesized thar nonconserved, potential contact sites partially account for the existence of different dominant binding regions for type-specific neutralizing antibodies.
引用
收藏
页码:607 / 618
页数:12
相关论文
共 43 条
[1]   Mapping of the antibody-binding regions on botulinum neurotoxin H-chain domain 855-1296 with antitoxin antibodies from three host species [J].
Atassi, MZ ;
Dolimbek, BZ ;
Hayakari, M ;
Middlebrook, JL ;
Whitney, B ;
Oshima, M .
JOURNAL OF PROTEIN CHEMISTRY, 1996, 15 (07) :691-700
[2]  
ATASSI MZ, 1985, CRIT REV IMMUNOL, V5, P387
[3]   PRECISE DETERMINATION OF THE ENTIRE ANTIGENIC STRUCTURE OF LYSOZYME - MOLECULAR FEATURES OF PROTEIN ANTIGENIC STRUCTURES AND POTENTIAL OF SURFACE-SIMULATION SYNTHESIS - POWERFUL NEW CONCEPT FOR PROTEIN-BINDING SITES [J].
ATASSI, MZ .
IMMUNOCHEMISTRY, 1978, 15 (12) :909-&
[4]   PREPARATION OF CONJUGATES USING 2 TETANUS TOXIN DERIVED FRAGMENTS - THEIR BINDING TO GANGLIOSIDES AND ISOLATED SYNAPTIC-MEMBRANES AND THEIR IMMUNOLOGICAL PROPERTIES [J].
BIZZINI, B ;
AKERT, K ;
GLICKSMAN, M ;
GROB, P .
TOXICON, 1980, 18 (5-6) :561-572
[5]  
BRANDEN BC, 1994, J MOL BIOL, V243, P767
[6]   3-DIMENSIONAL STRUCTURE OF A HETEROCLITIC ANTIGEN-ANTIBODY CROSS-REACTION COMPLEX [J].
CHITARRA, V ;
ALZARI, PM ;
BENTLEY, GA ;
BHAT, TN ;
EISELE, JL ;
HOUDUSSE, A ;
LESCAR, J ;
SOUCHON, H ;
POLJAK, RJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (16) :7711-7715
[7]   PROTECTIVE VACCINATION WITH A RECOMBINANT FRAGMENT OF CLOSTRIDIUM-BOTULINUM NEUROTOXIN SEROTYPE A EXPRESSED FROM A SYNTHETIC GENE IN ESCHERICHIA-COLI [J].
CLAYTON, MA ;
CLAYTON, JM ;
BROWN, DR ;
MIDDLEBROOK, JL .
INFECTION AND IMMUNITY, 1995, 63 (07) :2738-2742
[8]   Mapping of protective and cross-reactive domains of the type A neurotoxin of Clostridium botulinum [J].
Dertzbaugh, MT ;
West, MW .
VACCINE, 1996, 14 (16) :1538-1544
[9]  
DERTZBAUGH MT, 1995, 1 INT C MOL GEN PATH, P12
[10]   A COMPREHENSIVE SET OF SEQUENCE-ANALYSIS PROGRAMS FOR THE VAX [J].
DEVEREUX, J ;
HAEBERLI, P ;
SMITHIES, O .
NUCLEIC ACIDS RESEARCH, 1984, 12 (01) :387-395